These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37203823)

  • 21. Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus.
    Fu L; Zhou Y; Sun J; Zhu Z; Xing Z; Zhou S; Wang Y; Tai S
    Cardiovasc Diabetol; 2021 Oct; 20(1):201. PubMed ID: 34610830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Association Between Atherogenic Index of Plasma and No-Reflow Phenomenon in Acute Coronary Syndrome.
    Çelik İE; Öztürk S; Yarlıoğlu M; Barutçu O; Akgün O; Duran M; Yorulmaz Ş; Murat SN
    Anatol J Cardiol; 2023 Dec; 27(12):712-719. PubMed ID: 37807878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atherogenic Index of Plasma Is an Independent Risk Factor for Coronary Artery Disease and a Higher SYNTAX Score.
    Wang L; Chen F; Xiaoqi C; Yujun C; Zijie L
    Angiology; 2021 Feb; 72(2):181-186. PubMed ID: 32815391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Triglyceride-Glucose Index is Associated With Poor Prognosis in Patients With Acute Coronary Syndrome in Long-Term Follow-Up.
    Karadeniz FÖ; Sancaktepe EA; Karadeniz Y
    Angiology; 2023 Feb; 74(2):139-148. PubMed ID: 36112779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China.
    Qin Z; Zhou K; Li Y; Cheng W; Wang Z; Wang J; Gao F; Yang L; Xu Y; Wu Y; He H; Zhou Y
    Cardiovasc Diabetol; 2020 Feb; 19(1):23. PubMed ID: 32085772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atherogenic index of plasma predicts cerebrovascular accident occurrence in antineutrophil cytoplasmic antibody-associated vasculitis.
    Ahn SS; Lee LE; Pyo JY; Song JJ; Park YB; Lee SW
    Lipids Health Dis; 2020 Aug; 19(1):184. PubMed ID: 32799861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atherogenic Index of Plasma and the Risk of In-Stent Restenosis in Patients with Acute Coronary Syndrome beyond the Traditional Risk Factors.
    Zhu Y; Chen M; Liu K; Gao A; Kong X; Liu Y; Han H; Li H; Zhu H; Zhang J; Zhao Y
    J Atheroscler Thromb; 2022 Aug; 29(8):1226-1235. PubMed ID: 34497172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atherogenic index of plasma and the risk of advanced subclinical coronary artery disease beyond traditional risk factors: An observational cohort study.
    Won KB; Jang MH; Park EJ; Park HB; Heo R; Han D; Chang HJ
    Clin Cardiol; 2020 Dec; 43(12):1398-1404. PubMed ID: 32815171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive value of the atherogenic index of plasma for chronic total occlusion before coronary angiography.
    Liu T; Liu J; Wu Z; Lv Y; Li W
    Clin Cardiol; 2021 Apr; 44(4):518-525. PubMed ID: 33751593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome.
    Wang L; Cong HL; Zhang JX; Hu YC; Wei A; Zhang YY; Yang H; Ren LB; Qi W; Li WY; Zhang R; Xu JH
    Cardiovasc Diabetol; 2020 Jun; 19(1):80. PubMed ID: 32534586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The burden of major adverse cardiac events in patients with coronary artery disease.
    Tsai IT; Wang CP; Lu YC; Hung WC; Wu CC; Lu LF; Chung FM; Hsu CC; Lee YJ; Yu TH
    BMC Cardiovasc Disord; 2017 Jan; 17(1):1. PubMed ID: 28052754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The atherogenic index of plasma (AIP) is a predictor for the severity of coronary artery disease.
    Li Y; Feng Y; Li S; Ma Y; Lin J; Wan J; Zhao M
    Front Cardiovasc Med; 2023; 10():1140215. PubMed ID: 37441702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronary severity score and C-reactive protein predict major adverse cardiovascular events in patients with stable coronary artery disease (from the Taichung CAD study).
    Pan HC; Sheu WH; Lee WJ; Lee WL; Liao YC; Wang KY; Lee IT; Wang JS; Liang KW
    Clin Chim Acta; 2015 May; 445():93-100. PubMed ID: 25818243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of triglyceride/glucose index with respect to coronary slow flow.
    Buber I; Nar R; Kaya D; Senol H; Adali MK; Nar G
    Bratisl Lek Listy; 2022; 123(8):585-588. PubMed ID: 35852510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CHA2DS2-VASc-HS score in non-ST elevation acute coronary syndrome patients: assessment of coronary artery disease severity and complexity and comparison to other scoring systems in the prediction of in-hospital major adverse cardiovascular events.
    Taşolar H; Çetin M; Ballı M; Bayramoğlu A; Otlu YÖ; Türkmen S; Aktürk E
    Anatol J Cardiol; 2016 Oct; 16(10):742-748. PubMed ID: 27025198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the relationship between renal resistive index and extent and complexity of coronary artery disease in patients with acute coronary syndrome.
    Quisi A; Kurt IH; Şahin DY; Kaypaklı O; Söker G; Kaya Ö; Allahverdiyev S; Genç Ö; Alıcı G; Koç M
    Kardiol Pol; 2017; 75(11):1199-1207. PubMed ID: 28715070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between triglyceride-glucose index and major adverse cardiovascular events in patients with acute coronary syndrome - dose-response meta-analysis.
    Akbar MR; Pranata R; Wibowo A; Irvan ; Sihite TA; Martha JW
    Nutr Metab Cardiovasc Dis; 2021 Oct; 31(11):3024-3030. PubMed ID: 34625361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Atherogenic Index of Plasma: A Powerful and Reliable Predictor for Coronary Artery Disease in Patients With Type 2 Diabetes.
    Zhou K; Qin Z; Tian J; Cui K; Yan Y; Lyu S
    Angiology; 2021 Nov; 72(10):934-941. PubMed ID: 33949211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention.
    Xiong S; Chen Q; Zhang Z; Chen Y; Hou J; Cui C; Cheng L; Su H; Long Y; Yang S; Qi L; Chen X; Liu H; Cai L
    Cardiovasc Diabetol; 2022 Jun; 21(1):115. PubMed ID: 35751060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association of atherogenic index of plasma with cardiovascular outcomes in patients with coronary artery disease: A systematic review and meta-analysis.
    Rabiee Rad M; Ghasempour Dabaghi G; Darouei B; Amani-Beni R
    Cardiovasc Diabetol; 2024 Apr; 23(1):119. PubMed ID: 38566139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.